ERIE INDEMNITY COMPANY (ERIE): what the price requires
At today's price, ERIE INDEMNITY COMPANY (ERIE) is priced for +0.9% earnings growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/ERIE
Headline
| Field | Value |
|---|---|
| Ticker | ERIE |
| Company | ERIE INDEMNITY COMPANY |
| Current price | $247.30/sh |
| Composition | Management fee revenue - policy issuance and renewal services 77% / Management fee revenue - administrative services 2% / Administrative services reimbursement revenue 21% / Service agreement revenue 1% |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | fee-financial |
| Implied earnings growth | 0.9% |
| Price-to-earnings | 20.5x |
| Earnings yield | 4.9% |
Solve inputs: computed at a 8.4% cost of equity with 4% terminal growth over a 5-year stage, on the latest fiscal year's GAAP earnings base; each 1pp of cost of equity moves the implied earnings growth ~5pp.
How unusual the bet is: within-range
| Reference | Value |
|---|---|
| vs own history | -0.65σ |
| cohort percentile (of 49 peers) | 43 |
| implied end-window share | 0% |
Valuation X-Ray
Every valuation family lands below the price. The price therefore requires assumptions beyond what those standard frames encode.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 1.50x | 2 | expensive |
| Earnings | — | 0 | — |
| Relative | 2.34x | 1 | expensive |
| Growth | 1.32x | 1 | expensive |
Families that call it expensive: Asset, Relative
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.2%); the inversion above states its own rate.
Per-Model Detail (n=4)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | — | — | no | — |
| Bank Fair Value (P/TBV) | — | $230.08 | 1.07x | yes | TBVPS $50.72 × 4.54x (ROE (TTM) 24.3% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption)) |
| Relative Valuation | Relative | $105.77 | 2.34x | yes | P/S fallback (negative EPS): Sector P/S 1.2x × TTM revenue — excluded from consensus |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $133.13 | 1.86x | yes | BV/sh $50.72, ROE (TTM) 24.3%, ke 9.3% |
| Two-Stage Excess Return | Asset | $216.17 | 1.14x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $187.06 | 1.32x | yes | Rev $4.1B, growth 5% (input: historical growth; tapered), Terminal P/S: 2.4x / 2.8x / 3.2x (bear / base = today's held flat / bull, cap 8x) |
| Peter Lynch Fair Value | Relative | $0.00 | — | no | Negative/zero EPS — earnings-based value floored at $0 |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | — | — | no | — |
| Residual Income | Asset | — | — | no | — |
| Graham Number | Asset | — | — | no | — |
| EV/EBITDA Relative | Relative | — | — | no | — |
| FCF Yield | Earnings | — | — | no | — |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | — | — | no | — |
| ROIC-Justified P/B | Asset | — | — | no | — |
| P/Sales Sector | Relative | — | — | no | — |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | — | — | no | — |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net cash | $54.0m |
| Net debt / NOPAT (after-tax) | -0.09x (net cash) |
| Net debt / operating income (pre-tax) | -0.07x (net cash) |
| Burning cash | no |
Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.
Bullet Takeaways
- Erie Indemnity is a capital-light fee business that earns a 25% management fee on the Erie Insurance Exchange's premiums with no underwriting risk, growing fee revenue 4.2% to $786.4 million in the latest quarter as Exchange premiums rose.
- The biggest specific risk is total dependence on a single counterparty: all revenue comes from the Exchange, and the central economic variable is a discretionary fee rate set by Erie Indemnity's own board, a related-party structure with no diversification.
- What to watch next is the Exchange's premium growth, which drives the fee, and any change to the 25% fee rate set at least annually, against a price near 18 times earnings.
Bull Case
The moat here is a contract most companies could only dream of writing for themselves. Erie Indemnity does not underwrite insurance and takes no claims risk. It manages the Erie Insurance Exchange, a separate reciprocal insurer owned by its policyholders, and is paid a management fee for doing so. The 10-K spells out the mechanics: the fee "is calculated by multiplying the management fee rate by the direct and affiliated assumed premiums written" by the Exchange, and the board "set the 2026 management fee rate again at 25%." Twenty-five cents of every premium dollar the Exchange writes flows to Erie Indemnity, with none of the loss-cost volatility that drags on a normal insurer. The company itself states that its earnings are "primarily driven by the management fee revenue generated for the services we provide." That is the cleanest fee stream in the financial sector.
Because the fee is a slice of premiums, growth is a function of the Exchange writing more business, and the Exchange is growing. Total personal-lines premiums written rose 8.3% to $9.2 billion in 2025, driven by a 9.4% increase in average premium per policy. In the first quarter of 2026, management fee revenue from policy issuance and renewal services grew 4.2% to $786.4 million on a 3.6% increase in Exchange premiums to $3.23 billion. Erie Indemnity captures rising premiums, whether from pricing or policy growth, without taking on the risk that those higher premiums are meant to cover. The business compounds when the insurance market hardens, and it does so with almost no incremental capital.
The capital-light economics produce a fortress with nothing to defend against. Erie Indemnity carries essentially no debt, and its balance sheet is a modest asset base supporting a high-return fee operation, total assets of $3.38 billion against shareholders' equity of $2.35 billion at quarter-end. Net income rose to $150.5 million in the quarter, with diluted Class A earnings of $2.88, and the board declared a $1.4625 quarterly dividend. A company that earns a fixed percentage of a growing premium pool, with no underwriting losses, no leverage, and a long history of dividend growth, is a rare combination of recurring revenue and capital efficiency. That quality is precisely why the market pays up for it.
Bear Case
The structural feature that makes Erie Indemnity so clean is also its single greatest fragility: the entire company depends on one counterparty it does not control. All of the management fee revenue comes from the Erie Insurance Exchange, a separate entity owned by its policyholders, and the fee rate is set by Erie Indemnity's own board "at least annually." That is a related-party arrangement with no diversification underneath it. If the Exchange's growth stalls, or if its financial health deteriorates, Erie Indemnity's revenue moves in lockstep. The filing is explicit that the Exchange's profitability and pricing "have a direct bearing on our management fee revenue," and that those pricing actions are "subject to various regulatory requirements of the states." The company has no second business to fall back on, no underwriting income, no other client. It is a single-customer fee operation dressed as a diversified financial.
The governance angle compounds the concentration. The management fee rate, currently 25%, is the single most important variable in the company's economics, and it is set by a board that serves a company whose interests can diverge from the policyholders who own the Exchange. The rate has been held at 25%, but it is not contractually fixed forever, and any pressure to lower it, whether from policyholder advocacy, regulatory scrutiny, or competitive dynamics in the Exchange's markets, would cut directly into Erie Indemnity's earnings. A business whose profitability rests on a discretionary related-party rate carries a tail risk that a normal fee-for-service company does not.
The valuation leaves no room for either risk to surface. The stock trades at roughly 18 times earnings, a 5.5% earnings yield, and the trailing valuation methods price it well above where they land, the price sits at nearly twice the level the standard methods support. The forward fee-stream re-pricing is more generous because it credits continued premium growth, but reconciling the two, the trailing methods say expensive while the forward view credits the growth, the price is clearly paying a premium for the quality of the fee model rather than for cheapness. Erie Indemnity's implied earnings growth embedded in the price is barely positive, so even the forward case is not assuming aggressive expansion. The bear is straightforward: a premium multiple for a single-customer fee business whose central economic variable is a discretionary related-party rate, where any disruption to the Exchange or its fee leaves a richly priced stock with no cushion.
Valuation
What the price is paying for is quality, not growth. At roughly 18 times earnings, a 5.5% earnings yield, the embedded assumption is for essentially flat-to-slightly-declining earnings rather than rapid expansion; the price is not demanding aggressive growth from the business. For a capital-light fee operation that earns a fixed 25% of a growing premium pool with no underwriting risk, a modest implied-growth bar is plausible. The premium in the multiple is the market paying for the durability and cleanliness of the fee stream, not for a steep earnings ramp.
Here the two valuation systems point in different directions, and the reconciliation is the point. The trailing methods, which compare the price to earnings power and assets as they stand, place the price well above where they land, at roughly twice the level they support, marking the stock expensive on a static basis. The forward fee-stream view is more generous because it credits continued premium growth flowing through the 25% fee, and on that basis the price looks less stretched. Both are legitimate, and the gap between them is the whole valuation question: pay the premium and you are betting the fee model's durability justifies a price the static methods cannot, which is a reasonable bet for an asset this clean but a clear premium nonetheless.
Solvency is not the right frame for Erie Indemnity, which is the unusual part. It carries essentially no debt and takes no insurance risk, so leverage and coverage tests do not apply in the normal way; total assets of $3.38 billion sit against $2.35 billion of equity supporting a fee operation. The real risk is not financial fragility but revenue concentration: every dollar of fee income depends on the Erie Insurance Exchange continuing to grow its premiums and on the board maintaining the 25% rate. The decisive variable is therefore the Exchange's premium trajectory, which grew 3.6% in the latest quarter, and the durability of the fee rate. At this multiple the price already credits both holding up, so the margin for disappointment on either is thin.
Catalysts
The Q1 2026 report, released in late April, was the central recent catalyst and it showed steady fee growth. Net income improved to $150.5 million from $138.4 million a year earlier, with diluted Class A earnings of $2.88, and operating income rose to $166.8 million as revenue growth outpaced expenses. The engine performed as designed: management fee revenue from policy issuance and renewal services grew 4.2% to $786.4 million, reflecting a 3.6% increase in direct and affiliated assumed premiums written by the Exchange to $3.23 billion. Because the fee is a fixed percentage of premiums, the fee growth tracks the Exchange's premium growth almost directly.
Capital return continued on its steady cadence. The board declared a quarterly dividend of $1.4625 per Class A share in late April, payable in July. With no debt and a capital-light model, the dividend is funded comfortably from the recurring fee stream.
The figures to watch are the Exchange's premium trajectory, since that is what drives the fee, and the underlying retention and pricing trends behind it. The latest quarter noted slower premium growth and lower retention even as profitability improved, so whether premium growth reaccelerates is the key read on future fee growth. The other variable, less frequent but more consequential, is the annual setting of the management fee rate; it has been held at 25%, and any change would move earnings directly. The Exchange's own underwriting result, with a combined ratio near 99%, matters because the Exchange's financial health underpins the durability of the fee.
Peer Cohorts (Per Segment, With Filing Citations)
Management operations (single reportable segment) (reported)
- CRVL (CorVel Corporation)
- (no filing in the citation store)
- BRO (BROWN & BROWN, INC.)
- (no filing in the citation store)
- AJG (ARTHUR J. GALLAGHER & CO.)
- (no filing in the citation store)
- WTW (WILLIS TOWERS WATSON PLC)
- (no filing in the citation store)
- AON (Aon plc)
- (no filing in the citation store)
- RYAN (RYAN SPECIALTY HOLDINGS, INC.)
- (no filing in the citation store)
- BWIN (The Baldwin Insurance Group, Inc.)
- (no filing in the citation store)
- HGTY (HAGERTY, INC.)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
company 10-K, FY2025 · Q1 2026 earnings release